174 related articles for article (PubMed ID: 2286208)
1. Radiopharmaceuticals: state of the art.
Verbruggen AM
Eur J Nucl Med; 1990; 17(6-8):346-64. PubMed ID: 2286208
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Targeting monocytes and macrophages by means of SPECT and PET.
Van De Wiele C; Sathekge M; Maes A
Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):269-75. PubMed ID: 24844256
[TBL] [Abstract][Full Text] [Related]
4. Regional differences between 99mTc-ECD and 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults.
Inoue K; Nakagawa M; Goto R; Kinomura S; Sato T; Sato K; Fukuda H
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1489-97. PubMed ID: 14579088
[TBL] [Abstract][Full Text] [Related]
5. The significance of a dipyridamole induced 99mTc-MIBI perfusion abnormality on single photon emission tomography: a quantitative validation with labelled water and positron emission tomography.
Rechavia E; Galassi AR; Araujo LI; Halson P; Lammertsma AA; Jones T; Lavender JP; Maseri A
Eur J Nucl Med; 1992; 19(12):1044-9. PubMed ID: 1464357
[TBL] [Abstract][Full Text] [Related]
6. Imaging of cerebral blood flow with technetium-99m-HMPAO and technetium-99m-ECD: a comparison.
Asenbaum S; Brücke T; Pirker W; Pietrzyk U; Podreka I
J Nucl Med; 1998 Apr; 39(4):613-8. PubMed ID: 9544665
[TBL] [Abstract][Full Text] [Related]
7. Compartmental modeling of technetium-99m-labeled teboroxime with dynamic single-photon emission computed tomography: comparison with static thallium-201 in a canine model.
Di Bella EV; Ross SG; Kadrmas DJ; Khare HS; Christian PE; McJames S; Gullberg AG
Invest Radiol; 2001 Mar; 36(3):178-85. PubMed ID: 11228582
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of technetium-99m-L,L-EC in renal transplant recipients: a comparative study with technetium-99m-MAG3 and iodine-125-OIH.
Stoffel M; Jamar F; Van Nerom C; Verbruggen A; Mourad M; Leners N; Squifflet JP; Beckers C
J Nucl Med; 1994 Dec; 35(12):1951-8. PubMed ID: 7989976
[TBL] [Abstract][Full Text] [Related]
9. The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroxime.
Berman DS; Kiat H; Maddahi J
Circulation; 1991 Sep; 84(3 Suppl):I7-21. PubMed ID: 1832100
[TBL] [Abstract][Full Text] [Related]
10. Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects.
Léveillé J; Demonceau G; Walovitch RC
J Nucl Med; 1992 Apr; 33(4):480-4. PubMed ID: 1552328
[TBL] [Abstract][Full Text] [Related]
11. Quality control on radiochemical purity in Technetium-99m radiopharmaceuticals labelling: three years of experience on 2280 procedures.
Maioli C; Luciniani G; Strinchini A; Tagliabue L; Del Sole A
Acta Biomed; 2017 Apr; 88(1):49-56. PubMed ID: 28467334
[TBL] [Abstract][Full Text] [Related]
12. New agents labelled with technetium 99m for myocardial perfusion imaging.
Taillefer R
Can Assoc Radiol J; 1992 Aug; 43(4):258-66. PubMed ID: 1386280
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of 99mTc-ECD and 99mTc-HMPAO for peri-ictal SPECT: qualitative and quantitative analysis.
O'Brien TJ; Brinkmann BH; Mullan BP; So EL; Hauser MF; O'Connor MK; Hung J; Jack CR
J Neurol Neurosurg Psychiatry; 1999 Mar; 66(3):331-9. PubMed ID: 10084532
[TBL] [Abstract][Full Text] [Related]
14. Technetium-99m-labelled HL91 and technetium-99m-labelled MIBI SPECT imaging for the detection of ischaemic viable myocardium: a preliminary study.
Liu M; Ma Z; Guo X; Zhu J; Su J
Clin Physiol Funct Imaging; 2012 Jan; 32(1):25-32. PubMed ID: 22152075
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of technetium-99m-L,L-ethylenedicysteine in patients with chronic renal failure.
Prvulovich EM; Bomanji JB; Waddington WA; Rudrasingham P; Verbruggen AM; Ell PJ
J Nucl Med; 1997 May; 38(5):809-14. PubMed ID: 9170451
[TBL] [Abstract][Full Text] [Related]
16. Different uptake of 99mTc-ECD adn 99mTc-HMPAO in the same brains: analysis by statistical parametric mapping.
Hyun Y; Lee JS; Rha JH; Lee IK; Ha CK; Lee DS
Eur J Nucl Med; 2001 Feb; 28(2):191-7. PubMed ID: 11303889
[TBL] [Abstract][Full Text] [Related]
17. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease.
van Dyck CH; Lin CH; Smith EO; Wisniewski G; Cellar J; Robinson R; Narayan M; Bennett A; Delaney RC; Bronen RA; Hoffer PB
J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168
[TBL] [Abstract][Full Text] [Related]
18. Intra-individual differences between technetium-99m-HMPAO and technetium-99m-ECD in the normal medial temporal lobe.
Oku N; Matsumoto M; Hashikawa K; Moriwaki H; Ishida M; Seike Y; Terakawa H; Watanabe Y; Uehara T; Nishimura T
J Nucl Med; 1997 Jul; 38(7):1109-11. PubMed ID: 9225799
[TBL] [Abstract][Full Text] [Related]
19. Discordance of technetium-99m-HMPAO and technetium-99m-ECD SPECT in herpes simplex encephalitis.
Rieck H; Adelwöhrer C; Lungenschmid K; Deisenhammer E
J Nucl Med; 1998 Sep; 39(9):1508-10. PubMed ID: 9744332
[TBL] [Abstract][Full Text] [Related]
20. Carbon-11 and fluorine-18 chemistry devoted to molecular probes for imaging the brain with positron emission tomography.
Dollé F
J Labelled Comp Radiopharm; 2013; 56(3-4):65-7. PubMed ID: 24285311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
